Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)



21 Mar.
Geneva, Switzerland

Adjuvant and formulation training


The next adjuvant training course, which is co-organized by ENOVA and TRANSVAC2, will take place from the 21st-24th of March 2022 in Geneva, Switzerland. 

Application Deadline:  
15th of December 2021

More info here

29 Mar.
Galilee, Israel

Make space in your calendar for the 5th ENOVA workshop on adjuvants in Galilee, Israel. Time March 29-31 - 2022. More info will follow soon